Literature DB >> 12460345

Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia.

B Nørby1, H V Nielsen, P C Frimodt-Møller.   

Abstract

OBJECTIVE: To compare the efficacy and frequency of complications of transurethral interstitial laser coagulation (ILC) and transurethral microwave thermotherapy (TUMT) with transurethral resection or incision of the prostate (TURP/TUIP) in patients with symptomatic benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: Forty-eight patients were randomized to undergo ILC, 46 to TUMT and 24 to TURP/TUIP; they were followed for 6 months and the outcome analysed on an intention-to-treat basis.
RESULTS: At 6 months the symptom scores and maximum urinary flow rate (Qmax) had improved significantly in all groups. At 6 months the mean symptom score was 9.2 in both experimental groups and 6.8 in the control group (P > 0.05); the mean Qmax was 20.6 mL/s in the control group, 16.2 in the ILC group (P > 0.05 vs control) and 13.2 in the TUMT group (P < 0.05 vs. the control group). In the TUMT group patients developing urinary retention afterward had a significantly greater increase in Qmax than those who did not. The types of complications in the three groups varied. Urinary tract infection occurred frequently in the experimental groups, especially after ILC, whereas the 'well-known' complications of TURP occurred in the control group. Overall, 36% in the ILC, 54% in the TUMT and 73% in the control group had no complications (retrograde ejaculation excluded) during the first 6 months. One patient in the TUMT group underwent TURP after 3 months, whereas no patients in the ILC or the con-trol group were re-treated for BPH within the first 6 months.
CONCLUSION: In the short term both ILC and TUMT are reasonable alternatives to standard transurethral surgery for symptomatic BPH, where the reduction of symptoms is the primary goal of treatment. However, both ILC and TUMT were associated with morbidity, although the complication profiles differed from those after TURP/TUIP. Both ILC and TUMT seem advantageous in some patients because of the reduced risk of bleeding and the eliminated risk of TUR syndrome, and because TUMT only requires local anaesthesia. Thus, as neither treatment is better in all aspects, the advantages of one technique over the other must be weighed when deciding how to treat each patient.

Entities:  

Mesh:

Year:  2002        PMID: 12460345     DOI: 10.1046/j.1464-410x.2002.03031.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  15 in total

Review 1.  Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?

Authors:  T R W Herrmann; A J Gross; D Schultheiss; P M Kaufmann; U Jonas; M Burchardt
Journal:  World J Urol       Date:  2006-06-03       Impact factor: 4.226

Review 2.  The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review.

Authors:  Ryan W Frieben; Hao-Cheng Lin; Peter P Hinh; Francesco Berardinelli; Steven E Canfield; Run Wang
Journal:  Asian J Androl       Date:  2010-05-17       Impact factor: 3.285

Review 3.  Convective Radiofrequency Water Vapor Thermal Therapy with Rezūm System.

Authors:  Sevann Helo; Bradley Holland; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2017-10       Impact factor: 3.092

4.  National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008).

Authors:  Bahaa S Malaeb; Xinhua Yu; A Marshall McBean; Sean P Elliott
Journal:  Urology       Date:  2012-05       Impact factor: 2.649

Review 5.  First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?

Authors:  Ricardo R Gonzalez; Steven A Kaplan
Journal:  World J Urol       Date:  2006-05-19       Impact factor: 4.226

6.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

7.  Medical therapy versus surgery and minimally invasive surgical therapies for lower urinary tract symptoms and benign prostatic hyperplasia: what makes better economic sense?

Authors:  Mark D Stovsky; Katherine Rhee; David Hartke
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 8.  The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

Authors:  Rachael L DiSantostefano; Andrea K Biddle; John P Lavelle
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 9.  Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: when is the fuss worth it?

Authors:  Werner W Hochreiter; Roger M Müller
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

10.  Transurethral Microwave Thermotherapy (TUMT) in the Treatment of Benign Prostatic Hyperplasia: A Preliminary Report.

Authors:  Roger J Ziętek; Zbigniew M Ziętek
Journal:  Med Sci Monit       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.